<DOC>
	<DOCNO>NCT00475020</DOCNO>
	<brief_summary>The goal clinical research study learn use combination fludarabine , busulfan , antithymocyte globulin ( ATG ) help control myelofibrosis myelodysplastic syndrome patient receive bone marrow blood stem cell transplant . The safety drug also study .</brief_summary>
	<brief_title>Allogeneic Stem Cell Transplantation Myelofibrosis</brief_title>
	<detailed_description>Busulfan chemotherapy drug kill cancer cell bind DNA , commonly used stem cell transplant . Fludarabine drug anti-leukemia immunosuppressive effect . ATG help reduce risk transplant rejection prevent graft versus host disease . You receive fludarabine vein 1 hour Days -5 -2 . You receive busulfan vein 3 hour Day -5 -2 immediately complete fludarabine . If unrelated mismatch donor , receive ATG vein 6 hour Days -3 -1 prevent graft versus host disease help engraftment . You first receive low-level `` test '' dose busulfan , blood sample ( 1 teaspoon time ) drawn pharmacokinetic ( PK ) test . This may do outpatient prior inpatient admission . PK test measure level study drug blood different time point . This information use decide next dose need reach target blood level match body size . About 11 total sample blood drawn PK test test dose first high-dose busulfan treatment . A heparin lock place vein low number needle stick need draws . If possible blood level test perform technical scheduling reason reason , receive standard fix busulfan dose without `` test dose . '' You receive donor bone marrow blood stem cell vein 1 hour Day 0 . Two ( 2 ) day stem cell infusion Day -2 , tacrolimus start non-stop infusion vein change oral tablet leave hospital . You continue take tacrolimus mouth , least 4 month . Four ( 4 ) dos Methotrexate give short infusion Day 1 , Day 3 , Day 6 Day 11 stem cell infusion . Both give decrease risk get graft-vs-host disease ( GvHD ) . Further immunosuppressive therapy methylprednisolone ( steroid ) drug may also use treat GvHD occur . You 3 teaspoonful blood drawn routine test every day hospital least 2 time week first 100 day transplant . You may need frequent blood transfusion may admit hospital receive antibiotic get fever . Three ( 3 ) teaspoonful blood bone marrow aspirate biopsy take 1 month , 3 month , 6 month , 12 month , 18 month , 24 month transplant check response treatment . After first 2 year , disease status follow yearly phone call letter regular doctor study doctor . Tests and/or procedure may perform scheduled time , doctor think need . You take study disease get bad treatment best interest . This investigational study . All drug use study FDA approve commercially available . About 110 patient take part study . All enrol MD Anderson .</detailed_description>
	<mesh_term>Primary Myelofibrosis</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<mesh_term>Fludarabine phosphate</mesh_term>
	<mesh_term>Busulfan</mesh_term>
	<mesh_term>Antilymphocyte Serum</mesh_term>
	<mesh_term>Vidarabine</mesh_term>
	<criteria>1 . Patients Idiopathic Myelofibrosis Myelofibrosis secondary Polycythemia Vera Essential Thrombocythemia Myelodysplastic syndrome without fibrosis . 2 . Patients 75 year younger 3 . Patients must HLA match least 9/10 antigen ( A , B , C , DQ DR ) match related unrelated donor . 4 . Patients must Zubrod PS 2 less . 5 . Creatinine &lt; 1.6 mg/dl 6 . Ejection fraction &gt; /= 40 % , unless clear cardiology 7 . Serum direct bilirubin &lt; 2 mg/dl ( unless due Gilbert 's syndrome ) , SGPT &lt; /= 4 x normal value 8 . FEV1 , FVC , DLCO &gt; /= 40 % expect . 9 . Negative Beta HCG test woman child bear potential define postmenopausal 12 month previous surgical sterilization . 1 . Uncontrolled lifethreatening infection 2 . HIV positive 3 . Patients Active viral hepatitis</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Idiopathic Myelofibrosis</keyword>
	<keyword>Myelofibrosis</keyword>
	<keyword>Essential Thrombocythemia</keyword>
	<keyword>Polycythemia Vera</keyword>
	<keyword>Busulfan</keyword>
	<keyword>Antithymocyte Globulin</keyword>
	<keyword>ATG</keyword>
	<keyword>Fludarabine</keyword>
	<keyword>Thymoglobulin</keyword>
</DOC>